Showing results (511-520 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|May 21, 2013
The 2'-Trifluoromethyl Analogue of Indomethacin Is a Potent and Selective COX-2 InhibitorAnna L Blobaum, Md Jashim Uddin, Andrew S Felts, et al.
ACS Medicinal Chemistry Letters|April 2, 2013
Structure Activity Relationship Study of the Cleistriosides and Cleistetrosides for Antibacterial/Anticancer ActivityPei Shi, Michelle C Silva, Hua-Yu Leo Wang, et al.
ACS Medicinal Chemistry Letters|January 24, 2013
Structure-activity relationships and molecular modeling of 1,2,4-triazoles as adenosine receptor antagonistsJens Carlsson, Dilip K Tosh, Khai Phan, et al.
ACS Medicinal Chemistry Letters|December 7, 2013
Computer-aided Drug Design: Using Numbers to your AdvantageJohn C Faver, M Nihan Ucisik, Wei Yang, et al.
ACS Medicinal Chemistry Letters|August 23, 2014
Stabilized helical peptides: a strategy to target protein-protein interactionsMark A Klein
ACS Medicinal Chemistry Letters|August 23, 2014
Discovery of a Potent Analgesic NOP and Opioid Receptor Agonist: CebranopadolStefan Schunk, Klaus Linz, Claudia Hinze, et al.
ACS Medicinal Chemistry Letters|August 23, 2014
Total Synthesis and Biological Studies of TMC-205 and Analogues as Anticancer Agents and Activators of SV40 PromoterYang Gao, Sami Osman, Kazunori Koide
ACS Medicinal Chemistry Letters|August 23, 2014
Factors influencing in vivo disposition of polymeric micelles on multiple administrationsEri Hara, Motoki Ueda, Akira Makino, et al.
ACS Medicinal Chemistry Letters|August 23, 2014
Identification of novel phenyl butenonyl C-glycosides with ureidyl and sulfonamidyl moieties as antimalarial agentsK Kumar G Ramakrishna, Sarika Gunjan, Akhilesh Kumar Shukla, et al.
ACS Medicinal Chemistry Letters|August 23, 2014
Modulation of Activity Profiles for Largazole-Based HDAC Inhibitors through Alteration of Prodrug PropertiesLilibeth A Salvador, Heekwang Park, Fatma H Al-Awadhi, et al.
Pageof 438